The global Hormone-Releasing Agonists market was valued at US$ 141 million in 2023 and is anticipated to reach US$ 242 million by 2030, witnessing a CAGR of 6.7% during the forecast period 2024-2030.

Hormone-Releasing Agonists Market

The market for hormone-releasing agonists may experience growth due to an aging population and increasing awareness of hormone-related conditions such as prostate cancer (for which hormone therapy is often used) and hormone deficiencies.

This report aims to provide a comprehensive presentation of the global market for Hormone-Releasing Agonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hormone-Releasing Agonists.

Report Scope

The Hormone-Releasing Agonists market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hormone-Releasing Agonists market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hormone-Releasing Agonists manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Hormone-Releasing Agonists Market Report

Report Metric	Details
Report Name	Hormone-Releasing Agonists Market
Accounted market size in 2023	US$ 141 million
Forecasted market size in 2030	US$ 242 million
CAGR	6.7%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Hormonal Therapy Immunotherapy Targeted Therapy Chemotherapy Others
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Johnson & Johnson, Astellas Pharma Inc, Ipsen Pharma, Sanofi, Bayer AG, AstraZeneca, Pfizer, Teva Pharmaceutical Industries, Abbott, GlaxoSmithKline
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hormone-Releasing Agonists manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hormone-Releasing Agonists in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Hormone-Releasing Agonists Market growing?

Ans: The Hormone-Releasing Agonists Market witnessing a CAGR of 6.7% during the forecast period 2024-2030.

What is the Hormone-Releasing Agonists Market size in 2030?

Ans: The Hormone-Releasing Agonists Market size in 2030 will be US$ 242 million.

Who are the main players in the Hormone-Releasing Agonists Market report?

Ans: The main players in the Hormone-Releasing Agonists Market are Johnson & Johnson, Astellas Pharma Inc, Ipsen Pharma, Sanofi, Bayer AG, AstraZeneca, Pfizer, Teva Pharmaceutical Industries, Abbott, GlaxoSmithKline

What are the Application segmentation covered in the Hormone-Releasing Agonists Market report?

Ans: The Applications covered in the Hormone-Releasing Agonists Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Hormone-Releasing Agonists Market report?

Ans: The Types covered in the Hormone-Releasing Agonists Market report are Hormonal Therapy, Immunotherapy, Targeted Therapy, Chemotherapy, Others

1 Hormone-Releasing Agonists Market Overview

1.1 Product Overview and Scope of Hormone-Releasing Agonists

1.2 Hormone-Releasing Agonists Segment by Type

1.2.1 Global Hormone-Releasing Agonists Market Value Comparison by Type (2024-2030)

1.2.2 Hormonal Therapy

1.2.3 Immunotherapy

1.2.4 Targeted Therapy

1.2.5 Chemotherapy

1.2.6 Others

1.3 Hormone-Releasing Agonists Segment by Application

1.3.1 Global Hormone-Releasing Agonists Market Value by Application: (2024-2030)

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Global Hormone-Releasing Agonists Market Size Estimates and Forecasts

1.4.1 Global Hormone-Releasing Agonists Revenue 2019-2030

1.4.2 Global Hormone-Releasing Agonists Sales 2019-2030

1.4.3 Global Hormone-Releasing Agonists Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Hormone-Releasing Agonists Market Competition by Manufacturers

2.1 Global Hormone-Releasing Agonists Sales Market Share by Manufacturers (2019-2024)

2.2 Global Hormone-Releasing Agonists Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Hormone-Releasing Agonists Average Price by Manufacturers (2019-2024)

2.4 Global Hormone-Releasing Agonists Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Hormone-Releasing Agonists, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Hormone-Releasing Agonists, Product Type & Application

2.7 Hormone-Releasing Agonists Market Competitive Situation and Trends

2.7.1 Hormone-Releasing Agonists Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Hormone-Releasing Agonists Players Market Share by Revenue

2.7.3 Global Hormone-Releasing Agonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Hormone-Releasing Agonists Retrospective Market Scenario by Region

3.1 Global Hormone-Releasing Agonists Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Hormone-Releasing Agonists Global Hormone-Releasing Agonists Sales by Region: 2019-2030

3.2.1 Global Hormone-Releasing Agonists Sales by Region: 2019-2024

3.2.2 Global Hormone-Releasing Agonists Sales by Region: 2025-2030

3.3 Global Hormone-Releasing Agonists Global Hormone-Releasing Agonists Revenue by Region: 2019-2030

3.3.1 Global Hormone-Releasing Agonists Revenue by Region: 2019-2024

3.3.2 Global Hormone-Releasing Agonists Revenue by Region: 2025-2030

3.4 North America Hormone-Releasing Agonists Market Facts & Figures by Country

3.4.1 North America Hormone-Releasing Agonists Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Hormone-Releasing Agonists Sales by Country (2019-2030)

3.4.3 North America Hormone-Releasing Agonists Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Hormone-Releasing Agonists Market Facts & Figures by Country

3.5.1 Europe Hormone-Releasing Agonists Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Hormone-Releasing Agonists Sales by Country (2019-2030)

3.5.3 Europe Hormone-Releasing Agonists Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Hormone-Releasing Agonists Market Facts & Figures by Country

3.6.1 Asia Pacific Hormone-Releasing Agonists Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Hormone-Releasing Agonists Sales by Country (2019-2030)

3.6.3 Asia Pacific Hormone-Releasing Agonists Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Hormone-Releasing Agonists Market Facts & Figures by Country

3.7.1 Latin America Hormone-Releasing Agonists Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Hormone-Releasing Agonists Sales by Country (2019-2030)

3.7.3 Latin America Hormone-Releasing Agonists Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Hormone-Releasing Agonists Market Facts & Figures by Country

3.8.1 Middle East and Africa Hormone-Releasing Agonists Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Hormone-Releasing Agonists Sales by Country (2019-2030)

3.8.3 Middle East and Africa Hormone-Releasing Agonists Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Hormone-Releasing Agonists Sales by Type (2019-2030)

4.1.1 Global Hormone-Releasing Agonists Sales by Type (2019-2024)

4.1.2 Global Hormone-Releasing Agonists Sales by Type (2025-2030)

4.1.3 Global Hormone-Releasing Agonists Sales Market Share by Type (2019-2030)

4.2 Global Hormone-Releasing Agonists Revenue by Type (2019-2030)

4.2.1 Global Hormone-Releasing Agonists Revenue by Type (2019-2024)

4.2.2 Global Hormone-Releasing Agonists Revenue by Type (2025-2030)

4.2.3 Global Hormone-Releasing Agonists Revenue Market Share by Type (2019-2030)

4.3 Global Hormone-Releasing Agonists Price by Type (2019-2030)

5 Segment by Application

5.1 Global Hormone-Releasing Agonists Sales by Application (2019-2030)

5.1.1 Global Hormone-Releasing Agonists Sales by Application (2019-2024)

5.1.2 Global Hormone-Releasing Agonists Sales by Application (2025-2030)

5.1.3 Global Hormone-Releasing Agonists Sales Market Share by Application (2019-2030)

5.2 Global Hormone-Releasing Agonists Revenue by Application (2019-2030)

5.2.1 Global Hormone-Releasing Agonists Revenue by Application (2019-2024)

5.2.2 Global Hormone-Releasing Agonists Revenue by Application (2025-2030)

5.2.3 Global Hormone-Releasing Agonists Revenue Market Share by Application (2019-2030)

5.3 Global Hormone-Releasing Agonists Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Johnson & Johnson

6.1.1 Johnson & Johnson Corporation Information

6.1.2 Johnson & Johnson Description and Business Overview

6.1.3 Johnson & Johnson Hormone-Releasing Agonists Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Johnson & Johnson Hormone-Releasing Agonists Product Portfolio

6.1.5 Johnson & Johnson Recent Developments/Updates

6.2 Astellas Pharma Inc

6.2.1 Astellas Pharma Inc Corporation Information

6.2.2 Astellas Pharma Inc Description and Business Overview

6.2.3 Astellas Pharma Inc Hormone-Releasing Agonists Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Astellas Pharma Inc Hormone-Releasing Agonists Product Portfolio

6.2.5 Astellas Pharma Inc Recent Developments/Updates

6.3 Ipsen Pharma

6.3.1 Ipsen Pharma Corporation Information

6.3.2 Ipsen Pharma Description and Business Overview

6.3.3 Ipsen Pharma Hormone-Releasing Agonists Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Ipsen Pharma Hormone-Releasing Agonists Product Portfolio

6.3.5 Ipsen Pharma Recent Developments/Updates

6.4 Sanofi

6.4.1 Sanofi Corporation Information

6.4.2 Sanofi Description and Business Overview

6.4.3 Sanofi Hormone-Releasing Agonists Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Sanofi Hormone-Releasing Agonists Product Portfolio

6.4.5 Sanofi Recent Developments/Updates

6.5 Bayer AG

6.5.1 Bayer AG Corporation Information

6.5.2 Bayer AG Description and Business Overview

6.5.3 Bayer AG Hormone-Releasing Agonists Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Bayer AG Hormone-Releasing Agonists Product Portfolio

6.5.5 Bayer AG Recent Developments/Updates

6.6 AstraZeneca

6.6.1 AstraZeneca Corporation Information

6.6.2 AstraZeneca Description and Business Overview

6.6.3 AstraZeneca Hormone-Releasing Agonists Sales, Revenue and Gross Margin (2019-2024)

6.6.4 AstraZeneca Hormone-Releasing Agonists Product Portfolio

6.6.5 AstraZeneca Recent Developments/Updates

6.7 Pfizer

6.6.1 Pfizer Corporation Information

6.6.2 Pfizer Description and Business Overview

6.6.3 Pfizer Hormone-Releasing Agonists Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Pfizer Hormone-Releasing Agonists Product Portfolio

6.7.5 Pfizer Recent Developments/Updates

6.8 Teva Pharmaceutical Industries

6.8.1 Teva Pharmaceutical Industries Corporation Information

6.8.2 Teva Pharmaceutical Industries Description and Business Overview

6.8.3 Teva Pharmaceutical Industries Hormone-Releasing Agonists Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Teva Pharmaceutical Industries Hormone-Releasing Agonists Product Portfolio

6.8.5 Teva Pharmaceutical Industries Recent Developments/Updates

6.9 Abbott

6.9.1 Abbott Corporation Information

6.9.2 Abbott Description and Business Overview

6.9.3 Abbott Hormone-Releasing Agonists Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Abbott Hormone-Releasing Agonists Product Portfolio

6.9.5 Abbott Recent Developments/Updates

6.10 GlaxoSmithKline

6.10.1 GlaxoSmithKline Corporation Information

6.10.2 GlaxoSmithKline Description and Business Overview

6.10.3 GlaxoSmithKline Hormone-Releasing Agonists Sales, Revenue and Gross Margin (2019-2024)

6.10.4 GlaxoSmithKline Hormone-Releasing Agonists Product Portfolio

6.10.5 GlaxoSmithKline Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Hormone-Releasing Agonists Industry Chain Analysis

7.2 Hormone-Releasing Agonists Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Hormone-Releasing Agonists Production Mode & Process

7.4 Hormone-Releasing Agonists Sales and Marketing

7.4.1 Hormone-Releasing Agonists Sales Channels

7.4.2 Hormone-Releasing Agonists Distributors

7.5 Hormone-Releasing Agonists Customers

8 Hormone-Releasing Agonists Market Dynamics

8.1 Hormone-Releasing Agonists Industry Trends

8.2 Hormone-Releasing Agonists Market Drivers

8.3 Hormone-Releasing Agonists Market Challenges

8.4 Hormone-Releasing Agonists Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Teva Pharmaceutical Industries

Abbott

GlaxoSmithKline PLC

List of Tables

Table 1. Global Hormone-Releasing Agonists Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Hormone-Releasing Agonists Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Hormone-Releasing Agonists Market Competitive Situation by Manufacturers in 2023

Table 4. Global Hormone-Releasing Agonists Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Hormone-Releasing Agonists Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Hormone-Releasing Agonists Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Hormone-Releasing Agonists Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Hormone-Releasing Agonists Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Hormone-Releasing Agonists, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Hormone-Releasing Agonists, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Hormone-Releasing Agonists, Product Type & Application

Table 12. Global Key Manufacturers of Hormone-Releasing Agonists, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Hormone-Releasing Agonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hormone-Releasing Agonists as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Hormone-Releasing Agonists Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Hormone-Releasing Agonists Sales by Region (2019-2024) & (K Units)

Table 18. Global Hormone-Releasing Agonists Sales Market Share by Region (2019-2024)

Table 19. Global Hormone-Releasing Agonists Sales by Region (2025-2030) & (K Units)

Table 20. Global Hormone-Releasing Agonists Sales Market Share by Region (2025-2030)

Table 21. Global Hormone-Releasing Agonists Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Hormone-Releasing Agonists Revenue Market Share by Region (2019-2024)

Table 23. Global Hormone-Releasing Agonists Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Hormone-Releasing Agonists Revenue Market Share by Region (2025-2030)

Table 25. North America Hormone-Releasing Agonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Hormone-Releasing Agonists Sales by Country (2019-2024) & (K Units)

Table 27. North America Hormone-Releasing Agonists Sales by Country (2025-2030) & (K Units)

Table 28. North America Hormone-Releasing Agonists Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Hormone-Releasing Agonists Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Hormone-Releasing Agonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Hormone-Releasing Agonists Sales by Country (2019-2024) & (K Units)

Table 32. Europe Hormone-Releasing Agonists Sales by Country (2025-2030) & (K Units)

Table 33. Europe Hormone-Releasing Agonists Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Hormone-Releasing Agonists Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Hormone-Releasing Agonists Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Hormone-Releasing Agonists Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Hormone-Releasing Agonists Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Hormone-Releasing Agonists Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Hormone-Releasing Agonists Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Hormone-Releasing Agonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Hormone-Releasing Agonists Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Hormone-Releasing Agonists Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Hormone-Releasing Agonists Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Hormone-Releasing Agonists Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Hormone-Releasing Agonists Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Hormone-Releasing Agonists Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Hormone-Releasing Agonists Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Hormone-Releasing Agonists Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Hormone-Releasing Agonists Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Hormone-Releasing Agonists Sales (K Units) by Type (2019-2024)

Table 51. Global Hormone-Releasing Agonists Sales (K Units) by Type (2025-2030)

Table 52. Global Hormone-Releasing Agonists Sales Market Share by Type (2019-2024)

Table 53. Global Hormone-Releasing Agonists Sales Market Share by Type (2025-2030)

Table 54. Global Hormone-Releasing Agonists Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Hormone-Releasing Agonists Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Hormone-Releasing Agonists Revenue Market Share by Type (2019-2024)

Table 57. Global Hormone-Releasing Agonists Revenue Market Share by Type (2025-2030)

Table 58. Global Hormone-Releasing Agonists Price (US$/Unit) by Type (2019-2024)

Table 59. Global Hormone-Releasing Agonists Price (US$/Unit) by Type (2025-2030)

Table 60. Global Hormone-Releasing Agonists Sales (K Units) by Application (2019-2024)

Table 61. Global Hormone-Releasing Agonists Sales (K Units) by Application (2025-2030)

Table 62. Global Hormone-Releasing Agonists Sales Market Share by Application (2019-2024)

Table 63. Global Hormone-Releasing Agonists Sales Market Share by Application (2025-2030)

Table 64. Global Hormone-Releasing Agonists Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Hormone-Releasing Agonists Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Hormone-Releasing Agonists Revenue Market Share by Application (2019-2024)

Table 67. Global Hormone-Releasing Agonists Revenue Market Share by Application (2025-2030)

Table 68. Global Hormone-Releasing Agonists Price (US$/Unit) by Application (2019-2024)

Table 69. Global Hormone-Releasing Agonists Price (US$/Unit) by Application (2025-2030)

Table 70. Johnson & Johnson Corporation Information

Table 71. Johnson & Johnson Description and Business Overview

Table 72. Johnson & Johnson Hormone-Releasing Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Johnson & Johnson Hormone-Releasing Agonists Product

Table 74. Johnson & Johnson Recent Developments/Updates

Table 75. Astellas Pharma Inc Corporation Information

Table 76. Astellas Pharma Inc Description and Business Overview

Table 77. Astellas Pharma Inc Hormone-Releasing Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Astellas Pharma Inc Hormone-Releasing Agonists Product

Table 79. Astellas Pharma Inc Recent Developments/Updates

Table 80. Ipsen Pharma Corporation Information

Table 81. Ipsen Pharma Description and Business Overview

Table 82. Ipsen Pharma Hormone-Releasing Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Ipsen Pharma Hormone-Releasing Agonists Product

Table 84. Ipsen Pharma Recent Developments/Updates

Table 85. Sanofi Corporation Information

Table 86. Sanofi Description and Business Overview

Table 87. Sanofi Hormone-Releasing Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Sanofi Hormone-Releasing Agonists Product

Table 89. Sanofi Recent Developments/Updates

Table 90. Bayer AG Corporation Information

Table 91. Bayer AG Description and Business Overview

Table 92. Bayer AG Hormone-Releasing Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Bayer AG Hormone-Releasing Agonists Product

Table 94. Bayer AG Recent Developments/Updates

Table 95. AstraZeneca Corporation Information

Table 96. AstraZeneca Description and Business Overview

Table 97. AstraZeneca Hormone-Releasing Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. AstraZeneca Hormone-Releasing Agonists Product

Table 99. AstraZeneca Recent Developments/Updates

Table 100. Pfizer Corporation Information

Table 101. Pfizer Description and Business Overview

Table 102. Pfizer Hormone-Releasing Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Pfizer Hormone-Releasing Agonists Product

Table 104. Pfizer Recent Developments/Updates

Table 105. Teva Pharmaceutical Industries Corporation Information

Table 106. Teva Pharmaceutical Industries Description and Business Overview

Table 107. Teva Pharmaceutical Industries Hormone-Releasing Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Teva Pharmaceutical Industries Hormone-Releasing Agonists Product

Table 109. Teva Pharmaceutical Industries Recent Developments/Updates

Table 110. Abbott Corporation Information

Table 111. Abbott Description and Business Overview

Table 112. Abbott Hormone-Releasing Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Abbott Hormone-Releasing Agonists Product

Table 114. Abbott Recent Developments/Updates

Table 115. GlaxoSmithKline Corporation Information

Table 116. GlaxoSmithKline Description and Business Overview

Table 117. GlaxoSmithKline Hormone-Releasing Agonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. GlaxoSmithKline Hormone-Releasing Agonists Product

Table 119. GlaxoSmithKline Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Hormone-Releasing Agonists Distributors List

Table 123. Hormone-Releasing Agonists Customers List

Table 124. Hormone-Releasing Agonists Market Trends

Table 125. Hormone-Releasing Agonists Market Drivers

Table 126. Hormone-Releasing Agonists Market Challenges

Table 127. Hormone-Releasing Agonists Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Hormone-Releasing Agonists

Figure 2. Global Hormone-Releasing Agonists Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Hormone-Releasing Agonists Market Share by Type in 2023 & 2030

Figure 4. Hormonal Therapy Product Picture

Figure 5. Immunotherapy Product Picture

Figure 6. Targeted Therapy Product Picture

Figure 7. Chemotherapy Product Picture

Figure 8. Others Product Picture

Figure 9. Global Hormone-Releasing Agonists Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Hormone-Releasing Agonists Market Share by Application in 2023 & 2030

Figure 11. Hospital Pharmacies

Figure 12. Retail Pharmacies

Figure 13. Online Pharmacies

Figure 14. Global Hormone-Releasing Agonists Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Hormone-Releasing Agonists Market Size (2019-2030) & (US$ Million)

Figure 16. Global Hormone-Releasing Agonists Sales (2019-2030) & (K Units)

Figure 17. Global Hormone-Releasing Agonists Average Price (US$/Unit) & (2019-2030)

Figure 18. Hormone-Releasing Agonists Report Years Considered

Figure 19. Hormone-Releasing Agonists Sales Share by Manufacturers in 2023

Figure 20. Global Hormone-Releasing Agonists Revenue Share by Manufacturers in 2023

Figure 21. The Global 5 and 10 Largest Hormone-Releasing Agonists Players: Market Share by Revenue in 2023

Figure 22. Hormone-Releasing Agonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 23. Global Hormone-Releasing Agonists Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 24. North America Hormone-Releasing Agonists Sales Market Share by Country (2019-2030)

Figure 25. North America Hormone-Releasing Agonists Revenue Market Share by Country (2019-2030)

Figure 26. United States Hormone-Releasing Agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Canada Hormone-Releasing Agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. Europe Hormone-Releasing Agonists Sales Market Share by Country (2019-2030)

Figure 29. Europe Hormone-Releasing Agonists Revenue Market Share by Country (2019-2030)

Figure 30. Germany Hormone-Releasing Agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. France Hormone-Releasing Agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. U.K. Hormone-Releasing Agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Italy Hormone-Releasing Agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Russia Hormone-Releasing Agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Asia Pacific Hormone-Releasing Agonists Sales Market Share by Region (2019-2030)

Figure 36. Asia Pacific Hormone-Releasing Agonists Revenue Market Share by Region (2019-2030)

Figure 37. China Hormone-Releasing Agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Japan Hormone-Releasing Agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. South Korea Hormone-Releasing Agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. India Hormone-Releasing Agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Australia Hormone-Releasing Agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. China Taiwan Hormone-Releasing Agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Hormone-Releasing Agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Latin America Hormone-Releasing Agonists Sales Market Share by Country (2019-2030)

Figure 45. Latin America Hormone-Releasing Agonists Revenue Market Share by Country (2019-2030)

Figure 46. Mexico Hormone-Releasing Agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Brazil Hormone-Releasing Agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Argentina Hormone-Releasing Agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Hormone-Releasing Agonists Sales Market Share by Country (2019-2030)

Figure 50. Middle East & Africa Hormone-Releasing Agonists Revenue Market Share by Country (2019-2030)

Figure 51. Turkey Hormone-Releasing Agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Hormone-Releasing Agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. UAE Hormone-Releasing Agonists Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Global Sales Market Share of Hormone-Releasing Agonists by Type (2019-2030)

Figure 55. Global Revenue Market Share of Hormone-Releasing Agonists by Type (2019-2030)

Figure 56. Global Hormone-Releasing Agonists Price (US$/Unit) by Type (2019-2030)

Figure 57. Global Sales Market Share of Hormone-Releasing Agonists by Application (2019-2030)

Figure 58. Global Revenue Market Share of Hormone-Releasing Agonists by Application (2019-2030)

Figure 59. Global Hormone-Releasing Agonists Price (US$/Unit) by Application (2019-2030)

Figure 60. Hormone-Releasing Agonists Value Chain

Figure 61. Hormone-Releasing Agonists Production Process

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Distributors Profiles

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Stainless Steel Medication Trolley Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-18N15820

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Instant Molecular Testing Service Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-33G15638

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Universal Cell Therapy Drug Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-14U15769

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Preclinical Toxicology Testing Service Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-1P15930

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions